glp 1 drugs and parkinson's disease for Glucagon-like peptide-1 glp 1 parkinson's disease GLP-1 Glucagon-like peptide-1 (GLP-1) receptor agonists

Curr Ther Res 1982;31:1042-1048

Glutathione IV therapy has been building momentum for a while now, praised for everything from skin brightening to cellular detox to sustained energy

Visomitin, also known as SKQ1, is a novel mitochondrion-targeting antioxidant

Indications: Guanethidine is no longer available in the USA due to lack of availability, but is available in the UK (wikipedia) Was used for severe cases of hypertension, either alone or as an adjunct drug Contraindications: Guanethidine can cause a hypertensive crisis in patients with pheochromocytoma due to the release of catecholamines (tyramine like action)

The purity of the peptide itself also plays a formidable role here